AbbVie and Shire terminated their $54 billion deal, killing the year’s biggest agreed-upon merger amid a U.S. government push against so-called inversion deals.
from WSJ.com: US Business http://ift.tt/1vEnQBP
via IFTTT
from WSJ.com: US Business http://ift.tt/1vEnQBP
via IFTTT
No comments:
Post a Comment